Literature DB >> 14529049

In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane.

Domenico Ribatti1, Giuseppe De Falco, Beatrice Nico, Roberto Ria, Enrico Crivellato, Angelo Vacca.   

Abstract

In this study, we set out to make a fine characterization of the angiogenic response induced by plasma cells obtained from patients with active-multiple myeloma (MM), in comparison with cells obtained from patients with non-active MM and benign lesions such as monoclonal gammopathy of undetermined significance (MGUS), in the chick embryo chorioallantoic membrane (CAM) assay. To achieve this we investigated the time-course of the angiogenic response induced by gelatin sponges soaked in the cell suspensions and implanted on the CAM surface from day 8 to day 12 of incubation by evaluating the number of vessels, of the vessel bifurcation and the intervascular distance at 24, 48, 72 and 96 h after the implants. The results show that plasma cell suspensions obtained from patients with active MM induce a vasoproliferative response that was significantly higher than that induced by cell suspensions obtained from patients with non-active MM or with MGUS, which is also a function of the day of implantation. In fact, implants made from day 8 to day 10 induce a strong angiogenic response, whereas those made from day 11 to day 12 do not. This finding might depend on the fact that CAM endothelium exhibits an intrinsically high mitotic rate until day 10. Thereafter, the endothelial mitotic index declines rapidly, and consequently cell suspensions implanted on the CAM of successively older embryos are not able to induce a vasoproliferative response in parallel with the reduced rates of growth of the CAM's endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14529049      PMCID: PMC1571164          DOI: 10.1046/j.1469-7580.2003.00220.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  24 in total

1.  Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.

Authors:  C Y Li; S Shan; Q Huang; R D Braun; J Lanzen; K Hu; P Lin; M W Dewhirst
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

2.  Bone marrow angiogenesis and progression in multiple myeloma.

Authors:  A Vacca; D Ribatti; L Roncali; G Ranieri; G Serio; F Silvestris; F Dammacco
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

3.  Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.

Authors:  D Ribatti; A Gualandris; M Belleri; L Massardi; B Nico; M Rusnati; P Dell'Era; A Vacca; L Roncali; M Presta
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

4.  Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Dev Biol       Date:  1974-06       Impact factor: 3.582

5.  Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.

Authors:  A Vacca; D Ribatti; M Presta; M Minischetti; M Iurlaro; R Ria; A Albini; F Bussolino; F Dammacco
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

Review 6.  Angiogenesis and anti-angiogenesis in hematological malignancies.

Authors:  Domenico Ribatti; Angelo Vacca; Franco Dammacco; Denis English
Journal:  J Hematother Stem Cell Res       Date:  2003-02

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane.

Authors:  D Ribatti; C Urbinati; B Nico; M Rusnati; L Roncali; M Presta
Journal:  Dev Biol       Date:  1995-07       Impact factor: 3.582

9.  The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Authors:  D Billadeau; G Ahmann; P Greipp; B Van Ness
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Avascular and vascular phases of tumour growth in the chick embryo.

Authors:  D Knighton; D Ausprunk; D Tapper; J Folkman
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

View more
  12 in total

Review 1.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

2.  Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells.

Authors:  Hao Chen; Liang Shi; Xiaoyang Yang; Shihui Li; Xiaoling Guo; Ling Pan
Journal:  Int J Hematol       Date:  2010-10-14       Impact factor: 2.490

3.  Ultrasonic mediated synthesis of monodispersed lanthanum hydroxide nanorods for possible bioimplant application.

Authors:  Dhandapani Harini; Anantanarayanan Rajaram; Rama Rajaram
Journal:  J Mater Sci Mater Med       Date:  2015-01-20       Impact factor: 3.896

4.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021

Review 5.  In vivo models of angiogenesis.

Authors:  K Norrby
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

6.  Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis.

Authors:  Junhui Hu; Moe Ishihara; Arnold I Chin; Lily Wu
Journal:  Precis Clin Med       Date:  2019-10-01

7.  In Vivo Modulation of Angiogenesis and Immune Response on a Collagen Matrix via Extracorporeal Shockwaves.

Authors:  Diana Heimes; Nadine Wiesmann; Jonas Eckrich; Juergen Brieger; Stefan Mattyasovszky; Peter Proff; Manuel Weber; James Deschner; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

Review 8.  CXCL8 Signaling in the Tumor Microenvironment.

Authors:  Sahana Asokan; Obul Reddy Bandapalli
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis.

Authors:  Yi Ma; Shaojun Zhao; Shutao Shen; Shixiong Fang; Zulu Ye; Zhi Shi; An Hong
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

10.  Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin.

Authors:  Domenica Mangieri; Beatrice Nico; Vincenzo Benagiano; Michela De Giorgis; Angelo Vacca; Domenico Ribatti
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.